Projects & PATENTS

FOUNDED PROJECTS

IMMUN-HUB 2019: immunotherapy against tumors. New small molecules and nanomedicine against cancer. 70000€ UNIMIB F.Re

FRRB Lombardia 2019 New frontiers of engineered nanovectors to improve treatment efficacy and safety in neurological disorders (NEVERMIND) 630000€ UNIMIB F.Re

H2020 JPND 2016 Development of novel multicellular in vitro models of Alzheimer disease-like BBB 982409€ UNIMIB 293160€ F.Re “Nanoparticles for therapy and diagnosis of Alzheimer Disease (NAD)”

Cariplo Bank Foundation. Project: Novel strategies for synthesis and functionalization of nano-and microparticles for biomedical use

Lombardy Region . Project :Network Enabled Drug Design

Lombardy Region. Project: Scouting of Technology Transfer

Fondazione Banca del Monte di Lombardia 2013: Evaluation of toxicity of nanopraticles designed for therapy of neurodegenerative diseases F. Re 50000€

Italian Ministry of University: Role of lipid rafts in the processing of Prion protein

European Center Nanomedicine CEN 2014 Smart Nanoparticles For Boosted Drug Brain Targeting;

H2020-MSCA-ITN-2014, Design and development of advanced NAnomedicines to overcome Biological BArriers and to treat severe diseases", NABBA

European Center Nanomedicine CEN 2014 mApoE-Functionalized Lipidic -and Polymeric- Nanocomposite for Human Glioblastoma Imaging and Treatment.


GRANTED PATENTS

WO 2009/150686E “Liposomes capable of effectively binding the beta-amyloid peptide”. Inventors: Massimo Masserini; Francesca Re, Maria Silvia Sesana.

WO 2014/00857 “Liposomes for treatment of Alzheimer Disease”. Inventors: Massimo Masserini; Francesca Re.

START-UP

2015- AmypoPharma Srl